Xenothera

Xenothera company information, Employees & Contact Information

Explore related pages

Xenothera email format Xenothera management contacts

Related company profiles:

XENOTHERA is a biotechnology company based 21 rue La Nouë Bras de Fer, 44000 Nantes, France.

Company Details

Employees
25
Founded
-
Address
1 Rue Vauban, Nantes,france 44000,france
Phone
33240412987
Email
co****@****era.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
xenothera.com
Keywords
des patients et de la santé publique..
HQ
Nantes, France
Competitors
PHAXIAM Therapeutics, Valneva, Cellectis, BIOASTER, MaaT Pharma, Abivax, Transgene, OSE Immunotherapeutics, Affilogic, Innate Pharma.
Looking for a particular Xenothera employee's phone or email?

Xenothera Questions

News

Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants - Frontiers

Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants Frontiers

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2 - Wiley Online Library

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2 Wiley Online Library

ESSA Pharma (EPIX) Shareholders Approve Acquisition by XenoThera - GuruFocus

ESSA Pharma (EPIX) Shareholders Approve Acquisition by XenoThera GuruFocus

Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19 - Frontiers

Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19 Frontiers

Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial - BioMed Central

Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial BioMed Central

XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants - Frontiers

XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants Frontiers

LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation - Frontiers

LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation Frontiers

Companies like Xenothera

PHAXIAM Therapeutics logo - Similar company to Xenothera

Phaxiam Therapeutics

72
MaaT Pharma logo - Similar company to Xenothera

Maat Pharma

85
Abivax logo - Similar company to Xenothera

Abivax

89
Valneva logo - Similar company to Xenothera

Valneva

661
Innate Pharma logo - Similar company to Xenothera

Innate Pharma

198
OSE Immunotherapeutics logo - Similar company to Xenothera

Ose Immunotherapeutics

82
Transgene logo - Similar company to Xenothera

Transgene

212
Cellectis logo - Similar company to Xenothera

Cellectis

237
BIOASTER logo - Similar company to Xenothera

Bioaster

106
Affilogic logo - Similar company to Xenothera

Affilogic

37

Top Xenothera Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant